Basal | 3 months | 6 months | 9 months | 12 months | |
---|---|---|---|---|---|
Donor variables | x | ||||
Age (years) | |||||
Gender | |||||
Type of donor (deceased versus living) | |||||
Recipient variables | x | ||||
Age (years) | |||||
Gender | |||||
Chronic kidney disease-related risk factors | x | ||||
Primary kidney disease | |||||
Renal replacement therapy before transplantation | |||||
Duration of renal replacement therapy before transplantation | |||||
Cold ischemia time | |||||
Pre-transplant cardiovascular risk factors | x | ||||
Weight (kg), height (m) and body mass index (kg/m2) | |||||
Pre-transplant systolic and diastolic blood pressure (BP) | |||||
Pre-transplant cholesterol (mg/dl), high-density lipoprotein (HDL) cholesterol (mg/dl), low-density lipoprotein (LDL) cholesterol (mg/dl), and triglycerides (mg/dl) | |||||
Cardiovascular events before transplantation | |||||
Previous malignancies | |||||
Left ventricular hypertrophy | |||||
Post-transplant cardiovascular risk factors | x | x | x | x | |
Body mass index (kg/m2) | |||||
Post-transplant systolic and diastolic blood pressure (BP) | |||||
New-onset diabetes mellitus after transplantation | |||||
Post-transplant left ventricular hypertrophy | |||||
Routine biochemistry at follow-up | x | x | x | x | x |
Creatinine (mg/dl), proteinuria (g/day), leukocyte count (number/l), hematocrit (%), hemoglobin (g/dl), serum albumin (g/dl), total cholesterol (mg/dl), HDL cholesterol (mg/dl), LDL cholesterol (mg/dl), and triglycerides (mg/dl) | |||||
Follow-up of kidney transplantation | x | x | x | x | |
Post-transplant cardiovascular events | |||||
Acute rejection episodes | |||||
Graft failure | |||||
Infections |